Salix Pharmaceuticals (SLXP) is reportedly a takeover target of Shire (SHPG) which is said to be working on a potential offer.
Which big pharmaceutical stocks should investors stay away from in 2015?
Trade-Ideas LLC identified Salix Pharmaceuticals (SLXP) as a post-market leader candidate
Trade-Ideas LLC identified Salix Pharmaceuticals (SLXP) as a "barbarian at the gate" (strong stocks crossing above resistance with today's range greater than 200%) candidate
Salix Pharmaceuticals, Ltd. (NASDAQ: SLXP) ("Salix" or the "Company") today announced the promotion of William P.
The law firm of Federman & Sherwood has launched an investigation into Salix Pharmaceuticals, Ltd.
Salix Pharmaceuticals, Ltd. (NASDAQ: SLXP) ("Salix" or the "Company") today announced that the Audit Committee of Salix's Board of Directors (the "Audit Committee"), in consultation with its outside advisors and management,...
In trading on Tuesday, shares of Salix Pharmaceuticals Ltd crossed above their 200 day moving average of $125.40, changing hands as high as $130.00 per share. Salix Pharmaceuticals Ltd shares are currently trading up about 4.7% on the day.
Trade-Ideas LLC identified Salix Pharmaceuticals (SLXP) as a "storm the castle" (crossing above the 200-day simple moving average on higher than normal relative volume) candidate
Pharming Group NV (EURONEXT: PHARM) and Salix Pharmaceuticals, Ltd.
Salix Pharmaceuticals, Ltd. (NASDAQ: SLXP) ("Salix" or the "Company") today announced that Carolyn Logan has informed the Board of her decision to retire as President and Chief Executive Officer, and as a director, of the...
Levi & Korsinsky announces that a class action lawsuit has been commenced in the United States District Court for the Southern District of New York on behalf of investors who purchased Salix Pharmaceuticals, Ltd.
Glancy Binkow & Goldberg LLP reminds investors of Salix Pharmaceuticals, Ltd.
The law firm of Lieff Cabraser Heimann & Bernstein, LLP reminds Salix Pharmaceuticals, Inc.
The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court for the Southern District of New York on behalf of...
Salix Pharmaceuticals, Ltd. (NASDAQ: SLXP) ("Salix" or the "Company") today announced that it is working cooperatively with its principal pharmaceutical wholesalers to accelerate the reduction of wholesaler inventory levels...
Levi & Korsinsky announces that a class action lawsuit has been commenced in the United States District Court for the Southern District of New York on behalf of investors who purchased Salix Pharmaceuticals, Ltd.
After a lackluster year, Cramer expects Google to deliver solid results come January when it reports earnings.
Law Offices of Howard G. Smith announces that a class action lawsuit has been filed in the United States District Court for the Southern District of New York on behalf of purchasers of the securities of Salix ...
Former United States Securities and Exchange Commission attorney Willie Briscoe, founder of The Briscoe Law Firm, PLLC, and the securities litigation firm of Powers Taylor LLP announce that a class action lawsuit...
Salix Pharmaceuticals, Ltd. (NASDAQ: SLXP) ("Salix" or the "Company") today announced that it has engaged Russell Reynolds Associates, a nationally recognized search firm, to conduct a comprehensive search to assist...
The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court for the Southern District of New York on...
The law firm of Lieff Cabraser Heimann & Bernstein, LLP announces that class action litigation has been brought on behalf of those who purchased or otherwise acquired the securities of Salix Pharmaceuticals, Inc.
Trade-Ideas LLC identified Salix Pharmaceuticals (SLXP) as a "dead cat bounce" (down big yesterday but up big today) candidate
Salix Pharmaceuticals SLXP has been downgraded by TheStreet Ratings from Buy to Hold with a ratings score of C+. TheStreet Ratings Team has this to say about their recommendation:
The trading panel discussed whether it would help or hurt Twitter if its CEO steps down and whether Coca-Cola has any fizz left in it.
Former Attorney General of Louisiana, Charles C. Foti, Jr.
The law firm of Federman & Sherwood has launched an investigation into Salix Pharmaceuticals, Ltd.
